Employees: 18,600
Size BrightView (BV) is a United States Industrials company (Miscellaneous Commercial Services) with a market value of $1.08B, the 2199th largest of 3,117 United States companies the cockpit tracks. Shares closed at $11.67 on 6 Nov 2026.
Performance Over six months the shares fell 10.0%, against -16.1% for the median peer and -1.1% for the United States market (cap-weighted) — 7th highest of 21 in its peer set.
Growth Revenue grew 1.4% over the last twelve months (peer median +10.6%); the operating margin is 4.2% (peer median 11.2%).
Valuation It trades at 20.6× forward earnings against a peer median of 19.7× (9th most expensive of 18).
Capital Return on invested capital runs 4.8 points below its cost of capital (8.2% WACC).
Backlog Backlog (remaining performance obligations) was $446M at 30 Jun 2026, down 9% on a year earlier — 0.2 years of trailing revenue. Backlog detail →
Short interest Short interest is 4.5% of the free float (15 Oct 2026).
Next results Next results expected around 10 Nov 2026 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $2.74B | $2.67B | $2.77B | $2.82B | $2.77B |
| Revenue growth | — | -3% | -2% | +1% | — |
| Gross profit | $558M | $593M | $610M | $634M | $622M |
| EBITDA | $317M | $332M | $302M | $275M | $270M |
| Net income | $20.3M | $56.0M | $66.4M | -$7.70M | $14.0M |
| Free cash flow | -$23.2M | $37.6M | $125M | $58.6M | -$400,000 |
| Capital expenditure | $237M | $254M | $78.4M | $71.3M | $107M |
| Total debt | $963M | $950M | $958M | $1.02B | $1.45B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | BV | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +11.6% | +0.6% | 6th highest of 21 |
| 6-month return | -10.0% | -16.1% | 7th highest of 21 |
| Distance from 52-week high | -22.2% | -34.8% | 6th highest of 21 |
| Revenue growth (TTM) | +1.4% | +10.6% | 5th lowest of 21 |
| Operating margin | 4.2% | 11.2% | 6th lowest of 21 |
| Forward P/E | 20.6× | 19.7× | 9th most expensive of 18 |
| ROIC minus cost of capital | -4.8 pp | +1.2 pp | 5th lowest of 19 |
| EV / EBITDA | 8.0× | 8.3× | 5th cheapest of 9 |
| Net debt / EBITDA | 3.0× | 0.7× | 4th most indebted of 10 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| BrightView BV | United States | $1.08B | -10% | +1% | 4% | 20.6× | n/a | n/a |
| Prosegur Cash CASH.MC | Spain | $1.09B | +5% | -5% | 11% | 9.6× | -13.0% | +5.7% |
| Beijing Cuiwei Tower 603123.SS | China | $1.07B | -23% | -12% | -18% | n/a | n/a | n/a |
| Smartgroup SIQ.AX | Australia | $1.06B | +1% | +10% | 37% | 16.8× | -0.5% | +8.8% |
| FESCO 600861.SS | China | $1.11B | -18% | +4% | 1% | 10.4× | n/a | n/a |
| Neurones NRO.PA | France | $1.04B | +5% | +7% | 9% | 17.1× | -8.3% | +10.3% |
| Naruida Technology 688522.SS | China | $1.14B | -28% | +20% | 14% | 22.0× | n/a | n/a |
| Graincorp GNC.AX | Australia | $1.02B | +9% | -2% | 0% | 46.7× | n/a | n/a |
| Willdan WLDN | United States | $1.01B | -25% | +18% | 7% | 14.5× | 15.4% | +11.8% |
| EMTEK (Shenzhen) 300938.SZ | China | $1.16B | -44% | +11% | 27% | 33.1× | n/a | n/a |
| SBT Ultrasonic Technology 688392.SS | China | $1.16B | -19% | +42% | 17% | 52.9× | n/a | n/a |
| Shenzhen Boshijie Technology 301608.SZ | China | $1.00B | -20% | +15% | 14% | 20.9× | n/a | n/a |
| Beijing Haitian Ruisheng Science Technology 688787.SS | China | $1.17B | -1% | +34% | 4% | 163.5× | n/a | n/a |
| GL events GLO.PA | France | $991M | -14% | +6% | 10% | 8.7× | 3.1% | +29.1% |
| Shanghai Action Education Tehnology 605098.SS | China | $991M | -10% | +15% | 40% | 16.3× | -3.0% | +16.4% |
| Rites RITES.NS | India | $990M | -15% | +11% | 20% | 19.7× | 19.8% | +5.3% |
| Shenzhen Aoni Electronic 301189.SZ | China | $1.18B | -17% | +139% | 2% | n/a | n/a | n/a |
| China East Education 0667.HK | Hong Kong | $1.18B | -18% | +16% | 22% | 8.4× | -6.1% | +4.1% |
| Resolute Holdings Management RHLD | United States | $1.20B | +39% | +10% | 9% | n/a | 26.0% | n/a |
| Jadard Technology 688252.SS | China | $1.22B | -12% | +6% | 12% | 23.8× | 13.3% | +31.3% |
| Vcanbio Cell & Gene Engineering 600645.SS | China | $1.23B | -32% | -6% | 12% | 45.0× | 11.0% | +1.9% |
BrightView reported $446M of remaining performance obligations at 30 Jun 2026, down 9% from a year earlier and down 7% from the previous quarter. That is 0.2 years of trailing revenue already under contract. Book-to-bill last quarter: 0.95.